DK233377A - Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner - Google Patents

Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner

Info

Publication number
DK233377A
DK233377A DK233377A DK233377A DK233377A DK 233377 A DK233377 A DK 233377A DK 233377 A DK233377 A DK 233377A DK 233377 A DK233377 A DK 233377A DK 233377 A DK233377 A DK 233377A
Authority
DK
Denmark
Prior art keywords
noraromatic
dehydro
prostaglandins
omega
procedure
Prior art date
Application number
DK233377A
Other languages
Danish (da)
English (en)
Inventor
C Gandolfi
F Faustini
W Moretti
M M Usardi
R Ceserani
Original Assignee
Erba C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2382676A external-priority patent/IT1060884B/it
Priority claimed from IT3045876A external-priority patent/IT1065450B/it
Application filed by Erba C filed Critical Erba C
Publication of DK233377A publication Critical patent/DK233377A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
DK233377A 1976-06-01 1977-05-26 Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner DK233377A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2382676A IT1060884B (it) 1976-06-01 1976-06-01 Aromatiche prostaglandine
IT3045876A IT1065450B (it) 1976-12-16 1976-12-16 Oxaprostaglandine

Publications (1)

Publication Number Publication Date
DK233377A true DK233377A (da) 1977-12-02

Family

ID=26328426

Family Applications (1)

Application Number Title Priority Date Filing Date
DK233377A DK233377A (da) 1976-06-01 1977-05-26 Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner

Country Status (18)

Country Link
US (1) US4195183A (hu)
JP (1) JPS52148044A (hu)
AT (2) AT356302B (hu)
AU (1) AU509127B2 (hu)
BE (1) BE855236A (hu)
CA (1) CA1115700A (hu)
CH (1) CH634831A5 (hu)
CS (1) CS192484B2 (hu)
DE (1) DE2721534A1 (hu)
DK (1) DK233377A (hu)
FR (1) FR2368473A1 (hu)
GB (1) GB1583263A (hu)
HU (1) HU181424B (hu)
IL (1) IL51877A (hu)
NL (1) NL7705701A (hu)
NZ (1) NZ184187A (hu)
SE (1) SE436026B (hu)
SU (1) SU932985A3 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO2003074481A2 (en) * 2002-03-01 2003-09-12 Allergan, Inc. Preparation of prostamides
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2011046569A1 (en) * 2009-10-16 2011-04-21 Cayman Chemical Company Process for the preparation of f-series prostaglandins
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
JP2020034682A (ja) 2018-08-29 2020-03-05 キオクシア株式会社 露光方法、露光制御装置および半導体装置の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
ZA765031B (en) * 1975-09-10 1977-10-26 Univ Chicago Fluorinated prostaglandins and related compounds and chemical process

Also Published As

Publication number Publication date
AU2465677A (en) 1978-11-02
GB1583263A (en) 1981-01-21
AT367747B (de) 1982-07-26
CA1115700A (en) 1982-01-05
FR2368473A1 (fr) 1978-05-19
AU509127B2 (en) 1980-04-24
CH634831A5 (en) 1983-02-28
HU181424B (en) 1983-07-28
US4195183A (en) 1980-03-25
SE7706310L (sv) 1977-12-02
ATA333477A (de) 1979-09-15
DE2721534A1 (de) 1977-12-15
SU932985A3 (ru) 1982-05-30
CS192484B2 (en) 1979-08-31
NL7705701A (nl) 1977-12-05
JPS52148044A (en) 1977-12-08
ATA383179A (de) 1981-12-15
NZ184187A (en) 1978-07-28
BE855236A (fr) 1977-11-30
JPS6140662B2 (hu) 1986-09-10
IL51877A (en) 1981-09-13
IL51877A0 (en) 1977-06-30
FR2368473B1 (hu) 1981-09-11
SE436026B (sv) 1984-11-05
AT356302B (de) 1980-04-25

Similar Documents

Publication Publication Date Title
DK30277A (da) Fremgangsmade til fremstilling af substituerede phenylamidiner
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK187577A (da) Fremgangsmade til fremstilling af 1,4-benzodioxsnderivater
DK233377A (da) Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK88777A (da) Fremgangsmade til fremstilling af substituerede azapuriner
DK271377A (da) Fremgangsmade til fremstilling af substituerede arylacetamidocephalosporiner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK566277A (da) Fremgangsmaade til fremstilling af 1-aminoalkyl3,4-diphenyl-1h-pyrazoler
DK301177A (da) Fremgangsmade til fremstilling af 6a,10a-cishexahydrodibenzopyranoner
DK368877A (da) Fremgangsmaade til fremstilling af aryloxy-1-amino-3-propanoler-2.
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK324577A (da) Fremgangsmade til fremstilling af glycerol-1,2-bis-aminoalkylethere
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK345477A (da) Fremgangsmaade til fremstilling af 2,3-dichloranisol
DK553077A (da) Fremgangsmaade til fremstilling af n-propylnorapomorphindiestere
DK301377A (da) Fremgangsmade til fremstilling af cishexahydrodibenzopyranoner
DK97177A (da) Fremgangsmade til fremstilling af cyanoalkylureidocephalosporiner